Grace Expands Fast Growing Pharma Portfolio through Acquisition of Fine Chemistry Business
Grace Expands Fast Growing Pharma Portfolio through Acquisition of Fine Chemistry Business W. R. Grace & Co. today announced that it has entered into a definitive agreement to acquire the Fine Chemistry Services business of ALBemarle Corporation for approximately $570 million, including $300 million paid in cash at closing and $270 million funded through the issuance to ALBemarle of non-participating preferred equity of a newly created Grace subsidiary. The acquisition significantly strengthens and … Highly Complementary Bolt-on Acquisition Accelerates Strategy of Building Higher Growth Po...
Source: investingnews.com